⚖UPC-Intel
🇪🇺 UPC

UPC_CFI_283/2026

Court
Paris Local Division
Type of action
procedural
Patent
Methods of Using Sustained Release Aminopyridine Compositions
Language
en
Claimant / applicant
  • Gowling WLG
Defendant / respondent
  • Merz Therapeutics GmbH
  • Merz Pharmaceuticals LLC
  • Merz Pharma France-Viatris Santé

Track this case

Get an email when a new order or decision is published in UPC_CFI_283/2026.

Decisions and documents (1)

Weekly digest

A weekly email summarising new published decisions across European patent courts.